Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease. (2011).
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease. (2014).

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. (2006).

Author(s): Sebastian Walther . Richard Mahlberg . Uta Eichmann . Dieter Kunz.

Dronabinol reduces nocturnal motor activity and agitation in patients with severe dementia. Thus, it represents a great potential for the safe treatment of alterations in dementia. View study